NOTICE: UCB's Online Funding Management and Collaborations Portal
As of September 26th, 2022, all Investigator Initiated Study, Grants, Sponsorship and Donation requests will be processed through our new software service and renamed – UCB eRequest Funding Management and Collaborations Portal. You may access the new portal here: https://erequest.ucb.com/
All in-process requests and active projects have been migrated to the new portal. Users with in-process/active requests-your email and contact information has also been moved over with your requests. Please use the Forgot Password? link to reset your password.
New users and users with previously closed requests- you will need to register as a new user in the system.
We look forward to working with you, thank you for your patience.
USA
Donations
At UCB, we live by our tagline, "Inspired by patients. Driven by Science." As a science-focused business, we recognize that science starts at watching the clouds cross the sky, hearing our heartbeat, or seeing the wonder of a caterpillar becoming a butterfly. We are driven by the idea we have a role to play in "Inspiring Science" for the next generation of scientists who may go on to develop solutions for the severe immunological and neurological conditions we address.
UCB in the U.S. makes proactive contributions to support the overall missions of recognized nonprofit organizations. UCB has long been a supporter in the community and aim to focus our U.S. charitable giving with a strategic focus on STEM organizations in the five U.S. markets where UCB has an office (Atlanta, Raleigh, Boston, Seattle, and Washington, D.C.) as well as giving special consideration to organizations that reach a population underserved with STEM education opportunities. Beyond STEM, giving may be tied to employee volunteer activities, public health, and our commitments to sustainability and diversity, equity, and inclusion.
At this time, UCB generally does not accept unsolicited requests from charitable donations from external organizations. For future consideration, you can submit a letter of request, along with the mission of your organization, priorities, and accomplishments to U.S. Corporate Communications and Public Affairs at uscommunications@ucb.com.
If your organization is selected as a recipient of a charitable donation, you will receive a letter from UCB confirming the donation amount and the process for accessing the funds. Our proactive giving model allows us to concentrate time and resources on organizations inspiring science now and in the future.
Grants
UCB in the U.S. provides educational grants for independent, accredited and non-accredited programs that foster increased understanding of scientific, clinical, and healthcare issues and contribute to the enhancement of patient care. Symposia, grand rounds, and web-based educations activities are a few examples.
All programs must be non-promotional in nature and should be focused on healthcare professionals, patients, and/or caregivers.
Follow this link to submit a grant request: https://erequest.ucb.com/
*Requests for the therapeutic area of Gastroenterology (Crohn’s Disease) should be submitted to Ferring Pharmaceuticals through the following link https://ferring.envisionpharma.com/vt_ferring/
Investigator-Initiated Studies
The aim of the UCB Investigator-Initiated Studies (IIS) program is to support unsolicited, and independently initiated and conducted, studies that have the potential to enhance medical and scientific knowledge.
Therapeutic Areas of Interest
UCB is primarily focused on the following areas of therapeutic expertise (alphabetically listed):
Ankylosing Spondylitis | Parkinson's Disease |
Axial Spondyloarthritis | Psoriatic Arthritis |
Crohn's Disease* | Restless Legs Syndrome |
Epilepsy | Rheumatoid Arthritis |
Low Bone Mass Disorder | Systemic Lupus Erythematosus |
UCB will also consider innovative ideas that enhance patient care and advance scientific knowledge.
UCB support may be provided in the form of funding and/or investigational drugs (product or compound manufactured/owned by UCB).
Submitting a Concept
UCB is using the eRequest on-line submission portal to manage all Investigator-Initiated Study requests worldwide. To submit a concept, please click here:
https://erequest.ucb.com/
An appropriate Review Committee will evaluate the submitted proposals. Depending on the therapeutic area, this review is performed monthly or bimonthly. If a concept is recommended for a full proposal submission, an IIS Team member will contact the applicant with further instructions.
eRequest is available for IIS submissions worldwide.
*Requests for the therapeutic area of Gastroenterology (Crohn’s Disease) should be submitted to Ferring Pharmaceuticals through the following link https://ferring.envisionpharma.com/vt_ferring/
Contact
You can contact your local UCB Medical Science Liaison or UCB Medical Affairs office in your country.
All IIS process queries should be sent to IISmailbox@ucb.com.